| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients H Sokol, B Pigneur, L Watterlot, O Lakhdari, LG Bermúdez-Humarán, ... Proceedings of the National Academy of Sciences 105 (43), 16731-16736, 2008 | 5041 | 2008 |
| Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment XC Morgan, TL Tickle, H Sokol, D Gevers, KL Devaney, DV Ward, ... Genome biology 13 (9), 1-18, 2012 | 3026 | 2012 |
| Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease A Agus, J Planchais, H Sokol Cell host & microbe 23 (6), 716-724, 2018 | 2207 | 2018 |
| The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age D Mariat, O Firmesse, F Levenez, VD Guimarăes, H Sokol, J Doré, ... BMC microbiology 9 (1), 1-6, 2009 | 2077 | 2009 |
| Low counts of Faecalibacterium prausnitzii in colitis microbiota H Sokol, P Seksik, JP Furet, O Firmesse, I Nion‐Larmurier, L Beaugerie, ... Inflammatory bowel diseases 15 (8), 1183-1189, 2009 | 1560 | 2009 |
| Gut microbiota-derived metabolites as key actors in inflammatory bowel disease A Lavelle, H Sokol Nature Reviews Gastroenterology & Hepatology 17 (4), 223-237, 2020 | 1427 | 2020 |
| CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands B Lamas, ML Richard, V Leducq, HP Pham, ML Michel, G Da Costa, ... Nature medicine 22 (6), 598-605, 2016 | 1335 | 2016 |
| Fungal microbiota dysbiosis in IBD H Sokol, V Leducq, H Aschard, HP Pham, S Jegou, C Landman, D Cohen, ... Gut 66 (6), 1039-1048, 2017 | 1283 | 2017 |
| European consensus conference on faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, H Tilg, M Rajilić-Stojanović, P Kump, R Satokari, ... Gut 66 (4), 569-580, 2017 | 1243 | 2017 |
| Faecalibacterium prausnitzii and human intestinal health S Miquel, R Martin, O Rossi, LG Bermudez-Humaran, JM Chatel, H Sokol, ... Current opinion in microbiology 16 (3), 255-261, 2013 | 1203 | 2013 |
| Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases H Duboc, S Rajca, D Rainteau, D Benarous, MA Maubert, E Quervain, ... Gut 62 (4), 531-539, 2013 | 933 | 2013 |
| Gut microbiota-derived metabolites as central regulators in metabolic disorders A Agus, K Clément, H Sokol Gut, 2020 | 917 | 2020 |
| A microbial signature for Crohn's disease V Pascal, M Pozuelo, N Borruel, F Casellas, D Campos, A Santiago, ... Gut 66 (5), 813-822, 2017 | 868 | 2017 |
| Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn’s disease E Quévrain, MA Maubert, C Michon, F Chain, R Marquant, J Tailhades, ... Gut 65 (3), 415-425, 2016 | 851 | 2016 |
| Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects R Daillère, M Vétizou, N Waldschmitt, T Yamazaki, C Isnard, ... Immunity 45 (4), 931-943, 2016 | 845 | 2016 |
| Specificities of the fecal microbiota in inflammatory bowel disease H Sokol, P Seksik, L Rigottier‐Gois, C Lay, P Lepage, I Podglajen, ... Inflammatory bowel diseases 12 (2), 106-111, 2006 | 565 | 2006 |
| Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome JM Natividad, A Agus, J Planchais, B Lamas, AC Jarry, R Martin, ... Cell metabolism 28 (5), 737-749. e4, 2018 | 514 | 2018 |
| Aryl hydrocarbon receptor and intestinal immunity B Lamas, JM Natividad, H Sokol Mucosal immunology 11 (4), 1024-1038, 2018 | 475 | 2018 |
| Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice JM Natividad, B Lamas, HP Pham, ML Michel, D Rainteau, C Bridonneau, ... Nature communications 9 (1), 1-15, 2018 | 465 | 2018 |
| International consensus conference on stool banking for faecal microbiota transplantation in clinical practice G Cammarota, G Ianiro, CR Kelly, BH Mullish, JR Allegretti, Z Kassam, ... Gut 68 (12), 2111-2121, 2019 | 461 | 2019 |
